Testing effectiveness (Phase 2)UnknownNCT05785728What this trial is testingDB-1202 Monotherapy in Advanced Solid TumorsWho this might be right forAdvanced Solid Tumor DualityBio Inc. 150
Not applicableLooking for participantsNCT07068542What this trial is testingSacituzumab Tirumotecan Combined With Immunotherapy in Advanced Thyroid CancerWho this might be right forAdvanced Thyroid CarcinomaRadioiodine-refractory Differentiated Thyroid CancerPoorly Differentiated Thyroid Carcinoma Zhejiang Provincial People's Hospital 94
Early research (Phase 1)WithdrawnNCT00937417What this trial is testingS0716 Vandetanib and Docetaxel in Treating Patients With Advanced Solid TumorsWho this might be right forBreast CancerHead and Neck CancerLung Cancer+2 more SWOG Cancer Research Network
Early research (Phase 1)Ended earlyNCT02313012What this trial is testingSafety and PK Study of CC-90003 in Relapsed/Refractory Solid TumorsWho this might be right forNeoplasm Metastasis Celgene 19
Testing effectiveness (Phase 2)Ended earlyNCT04161391What this trial is testingStudy of TPX-0046, A RET/SRC Inhibitor in Adult Subjects With Advanced Solid Tumors Harboring RET Fusions or MutationsWho this might be right forNon Small Cell Lung CancerMedullary Thyroid CancerRET Gene Mutation+2 more Turning Point Therapeutics, Inc. 41
Testing effectiveness (Phase 2)Study completedNCT00095836What this trial is testingGefitinib in Treating Patients With Locally Advanced or Metastatic Thyroid Cancer That Did Not Respond to Iodine TherapyWho this might be right forHead and Neck Cancer Massachusetts General Hospital 27
Early research (Phase 1)Active Not RecruitingNCT05907304What this trial is testingAssess Naporafenib (ERAS-254) Administered With Trametinib in Patients With RAS Q61X MutationsWho this might be right forAdvanced or Metastatic Solid Tumors Erasca, Inc. 86
Testing effectiveness (Phase 2)Study completedNCT04552769What this trial is testingAbemaciclib in Metastatic or Locally Advanced Anaplastic/Undifferentiated Thyroid CancerWho this might be right forThyroid CancerAnaplastic Thyroid CancerUndifferentiated Thyroid Cancer Stanford University 9
Large-scale testing (Phase 3)UnknownNCT03048877What this trial is testingEfficacy of Apatinib in Radioactive Iodine-refractory Differentiated Thyroid CancerWho this might be right forDifferentiated Thyroid Cancer Peking Union Medical College Hospital 118
Early research (Phase 1)Study completedNCT00413322What this trial is testingStudy of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid TumorsWho this might be right forTumor Valerio Therapeutics 35
Testing effectiveness (Phase 2)Study completedNCT04521348What this trial is testingMultiple Target Kinase Inhibitor and Anti-Programmed Death-1 Antibody in Patients With Advanced Thyroid CancerWho this might be right forThyroid Cancer Fudan University 103
Testing effectiveness (Phase 2)Ended earlyNCT00603941What this trial is testingCS7017, an Oral PPARγ Agonist, in Combination With PaclitaxelWho this might be right forAnaplastic Thyroid Cancer Daiichi Sankyo 19
Testing effectiveness (Phase 2)Ended earlyNCT02472080What this trial is testingGemcitabine - Oxaliplatin for Advanced Refractory Thyroid Cancer Patients: a Phase II StudyWho this might be right forThyroid Cancer Assistance Publique - Hôpitaux de Paris 21
Testing effectiveness (Phase 2)Study completedNCT01964144What this trial is testingAn Open-label, Multicenter, Phase II Study of Dovitinib in Advanced Thyroid CancerWho this might be right forThyroid Cancer Yonsei University 40
Testing effectiveness (Phase 2)Study completedNCT01164176What this trial is testingEverolimus in Treating Patients With Locally Advanced or Metastatic Thyroid CancerWho this might be right forHead and Neck Cancer Yonsei University 40
Large-scale testing (Phase 3)Study completedNCT01298323What this trial is testingStudy to Determine if Contacting Patients With MTC More Frequently Results in Earlier Detection and Treatment of Signs and Symptoms of AEs and Thus a Decrease in the Percentage of Time Patients Experience AEs During First 12 Months on Vandetanib TreatmentWho this might be right forLocally Advanced or Metastatic Medullary Thyroid CancerMedullary Thyroid Cancer Sanofi 205
Large-scale testing (Phase 3)Study completedNCT00984282What this trial is testingNexavar® Versus Placebo in Locally Advanced/Metastatic RAI-Refractory Differentiated Thyroid CancerWho this might be right forThyroid Neoplasms Bayer 417
Early research (Phase 1)Ended earlyNCT06336148What this trial is testingA Phase 1a/1b Study of ACTM-838 in Patients With Advanced Solid TumorsWho this might be right forSolid Tumor Actym Therapeutics, Inc. 10
Testing effectiveness (Phase 2)Study completedNCT03037385What this trial is testingPhase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid TumorsWho this might be right forRET-altered Non Small Cell Lung CancerMedullary Thyroid CancerRET-altered Papillary Thyroid Cancer+37 more Hoffmann-La Roche 590
Not applicableActive Not RecruitingNCT04970134What this trial is testingSpanish Study for Molecular Characterization of Thyroid CarcinomaWho this might be right forDifferentiated Thyroid CarcinomaMedullary Thyroid Carcinoma Grupo Español de Tratamiento de Tumores de Cabeza y Cuello 150